Genital herpes is a sexually transmitted diseases which are caused by viral pathogen, herpes simplex virus (HSV) is carried out via infected people’s semen, saliva and vaginal secretions.: HSV-and HSV-2 are two types of herpes simplex viruses. There are several common symptoms of genital herpes such as blisters on genital organs, blisters in the mouth, lips, etc, itchiness or tingling in the infected areas, pelvic pain, vaginal discharge, etc. Various type of genital herpes treatment such as medication, episodic treatment, and suppressive treatment, etc. Antiviral drugs such as Acyclovir, Famciclovir, and Valacyclovir are commercially available therapeutic for the treatment genital herpes.

For Additional Insights, Click to Access Complete Report -https://www.gmiresearch.com/report/global-genital-herpes-treatment-market/

Increasing prevalence of sexually transmitted disease especially genital herpes across the globe is expected to boost the demand of genital herpes treatment over the forecast period. For instance, according to center for disease control and prevention approximately 50 million population affected with genital herpes in the U.S. Factors such as rising diagnosis rate in emerging countries and increasing clinical trial of vaccines for genital herpes has also driven the growth of the genital herpes market during the forecast period. Moreover, increasing awareness about sexually transmitted diseases and rise in government funding to develop innovative therapeutic for the genital herpes treatment spur the market growth during the forecast period. In addition, Accurate diagnostic tests such as competitive polymerase chain reactions (PCR), DNA enzyme immunoassay hybridization, real-time PCR assay are extensively used to diagnose STIs in developed countries. These tests are useful for the diagnosis of asymptomatic infections which would increase the demand for genital herpes treatment and drive the market. However, inadequate reimbursement and low treatment seeking rate for genital herpes, are some of the factors which hinder the growth of the market.

Request for Sample Report- https://www.gmiresearch.com/report/global-genital-herpes-treatment-market/sample-request

Various notable players operating in the market, include Novartis AG, GlaxoSmithKline, Genocea Biosciences, AiCuris, Vical, Maruho, Teva Pharmaceuticals Inc., Mylan Pharmaceuticals Inc.,, Apotheca Inc., Sandoz Inc., Hospira Inc., Novopharm Ltd., Dr. Reddy’s Laboratories Ltd .among others. Major players are focussing research and development activities to launch innovative therapeutic for the treatment of genital herpes. For instance, GEN-003 vaccines are currently under phase 3 of clinical trial for the treatment of genital herpes infections.

Request for Customization –https://www.gmiresearch.com/report/global-genital-herpes-treatment-market/request-for-customization

The global genital herpes treatment market has been segmented on the basis of drug type, route of administration, indication, distribution channel and key geographies. Based on drug type, the market comprises Acyclovir, Valacyclovir and Famciclovir. The research report “global genital herpes treatment market” provides in-depth analysis of global genital herpes treatment market based on drug type, route of administration, indication, distribution channel and major geographies for the forecast period from 2018 to 2025. The report also highlights the major market drivers propelling the growth as well as challenges faced by market participants. The research report provides growth, opportunity, market size, trends and forecast for the global genital herpes treatment market. In addition, the report also analyses the competitive landscape, major players and their strategies in 2018. The competitive landscape section of the report captures and highlights the recent developments, Company share, outlook.

Key questions answered in this research report:

At what pace is genital herpes treatment market growing? What will be the global genital herpes treatment market forecast?
What are the key drivers and restraints in the current market? What will be the impact of drivers and restraints in the future?
What are the regional revenue and forecast breakdowns? Which are the major regional revenue pockets for growth in genital herpes treatment and global genital herpes treatment market size?
Global genital herpes treatment market outlook, application areas and how they are poised to grow?
Global genital herpes treatment market overview, industry analysis and scope of study?

About GMI Research

GMI Research is a market research and consulting firm which provides research-based solutions to business executives and investment professionals so that they can make right business & investment decisions faster based on real facts. We help business leaders through independent fact-based insight, ensuring their business achieve success by beating the competition. GMI Research’s leadership team with extensive experience in research and consulting together with our research and domain expertise creates a strong value proposition to create solutions that addresses our client’s business problems and add significant value to long lasting relationship.

The company provides syndicated research report, customized research, sales enablement research, data analytics and KPO (knowledge process outsourcing) service for Electronics & Semiconductors, Information Communication and Technology, Energy & Power, Healthcare, Automotive, Transportation & Logistics and Chemical industries. Our analysts and consultants who are passionate about research and consulting are recruited from renowned local and global universities and have worked with the leading local and international organizations.